Published in Autoimmunity on February 01, 2006
Heterologous immunity between viruses. Immunol Rev (2010) 2.20
Localizing central nervous system immune surveillance: meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis. Ann Neurol (2009) 2.15
Molecular mimicry as a mechanism of autoimmune disease. Clin Rev Allergy Immunol (2012) 1.37
Blood-borne soluble protein antigen intensifies T cell activation in autoimmune CNS lesions and exacerbates clinical disease. Proc Natl Acad Sci U S A (2007) 1.13
Heterologous immunity: immunopathology, autoimmunity and protection during viral infections. Autoimmunity (2011) 0.98
Helicobacter pylori and autoimmune disease: cause or bystander. World J Gastroenterol (2014) 0.97
Myelin basic protein priming reduces the expression of Foxp3 in T cells via nitric oxide. J Immunol (2010) 0.97
Studies in the modulation of experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol (2010) 0.95
Exacerbated pathology of viral encephalitis in mice with central nervous system-specific autoantibodies. Am J Pathol (2007) 0.91
Experimental autoimmune encephalomyelitis as a testing paradigm for adjuvants and vaccines. Vaccine (2010) 0.91
Adipose-derived cell construct stabilizes heart function and increases microvascular perfusion in an established infarct. Stem Cells Transl Med (2013) 0.87
Potential triggers of MS. Results Probl Cell Differ (2010) 0.87
Sequential polymicrobial infections lead to CNS inflammatory disease: possible involvement of bystander activation in heterologous immunity. J Neuroimmunol (2007) 0.84
What do effective treatments for multiple sclerosis tell us about the molecular mechanisms involved in pathogenesis? Int J Mol Sci (2012) 0.81
Effects of acute and repeated exposure to lipopolysaccharide on cytokine and corticosterone production during remyelination. Brain Behav Immun (2007) 0.80
Fungal infection in cerebrospinal fluid from some patients with multiple sclerosis. Eur J Clin Microbiol Infect Dis (2013) 0.80
FTY720 (fingolimod) modulates the severity of viral-induced encephalomyelitis and demyelination. J Neuroinflammation (2014) 0.80
HTLV-1, Immune Response and Autoimmunity. Viruses (2015) 0.77
Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters. Inflammopharmacology (2014) 0.77
Unresolved issues in theories of autoimmune disease using myocarditis as a framework. J Theor Biol (2014) 0.75
Axonal pathology and demyelination in viral models of multiple sclerosis. Discov Med (2014) 0.75
Possible role of interleukin-17 in a prime/challenge model of multiple sclerosis. J Neurovirol (2012) 0.75
A literature review on the patients with autoimmune diseases following vaccination against infections. Hum Vaccin Immunother (2015) 0.75
Microorganisms and autoimmunity: making the barren field fertile? Nat Rev Microbiol (2003) 1.76
Axonal injury heralds virus-induced demyelination. Am J Pathol (2003) 1.38
Molecular mimicry as a mechanism of autoimmune disease. Clin Rev Allergy Immunol (2012) 1.37
Autistic disorder and viral infections. J Neurovirol (2005) 1.33
Seizures following picornavirus infection. Epilepsia (2008) 1.31
Innate but not adaptive immune responses contribute to behavioral seizures following viral infection. Epilepsia (2009) 1.26
Inside-Out versus Outside-In models for virus induced demyelination: axonal damage triggering demyelination. Springer Semin Immunopathol (2002) 1.24
Pathogenic epitopes, heterologous immunity and vaccine design. Nat Rev Microbiol (2007) 1.24
Interleukin-6, produced by resident cells of the central nervous system and infiltrating cells, contributes to the development of seizures following viral infection. J Virol (2011) 1.22
Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis. J Neuroimmunol (2006) 1.16
Purkinje cell death after uptake of anti-Yo antibodies in cerebellar slice cultures. J Neuropathol Exp Neurol (2010) 1.14
Development of postinfection epilepsy after Theiler's virus infection of C57BL/6 mice. J Neuropathol Exp Neurol (2010) 1.14
Distinct roles for IP-10/CXCL10 in three animal models, Theiler's virus infection, EAE, and MHV infection, for multiple sclerosis: implication of differing roles for IP-10. Mult Scler (2004) 1.08
Theiler's virus infection chronically alters seizure susceptibility. Epilepsia (2009) 1.05
Targeting inflammatory demyelinating lesions to sites of Wallerian degeneration. Am J Pathol (2007) 1.03
Neuropathogenesis of Theiler's murine encephalomyelitis virus infection, an animal model for multiple sclerosis. J Neuroimmune Pharmacol (2009) 1.01
T cell infiltration is associated with increased Lyme arthritis in TLR2-/- mice. FEMS Immunol Med Microbiol (2007) 1.01
Molecular mimicry in multiple sclerosis. Int Rev Neurobiol (2007) 0.98
Infiltrating macrophages are key to the development of seizures following virus infection. J Virol (2012) 0.98
Induction of autoreactive CD8+ cytotoxic T cells during Theiler's murine encephalomyelitis virus infection: implications for autoimmunity. J Virol (2002) 0.97
The pathologic role for COX-2 in apoptotic oligodendrocytes in virus induced demyelinating disease: implications for multiple sclerosis. J Neuroimmunol (2006) 0.96
Central nervous system pathology caused by autoreactive CD8+ T-cell clones following virus infection. J Virol (2005) 0.96
Diffusion basis spectrum imaging detects and distinguishes coexisting subclinical inflammation, demyelination and axonal injury in experimental autoimmune encephalomyelitis mice. NMR Biomed (2014) 0.96
Studies in the modulation of experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol (2010) 0.95
Massive apoptosis in lymphoid organs in animal models for primary and secondary progressive multiple sclerosis. Am J Pathol (2005) 0.94
Role for complement in the development of seizures following acute viral infection. J Virol (2010) 0.94
Regulatory T cells and Th17 cells in viral infections: implications for multiple sclerosis and myocarditis. Future Virol (2012) 0.93
Contrasting roles for axonal degeneration in an autoimmune versus viral model of multiple sclerosis: When can axonal injury be beneficial? Am J Pathol (2007) 0.92
Role of CD5+ B-1 cells in EAE pathogenesis. Autoimmunity (2008) 0.92
TGF-beta1 suppresses T cell infiltration and VP2 puff B mutation enhances apoptosis in acute polioencephalitis induced by Theiler's virus. J Neuroimmunol (2007) 0.91
Once initiated, viral encephalitis-induced seizures are consistent no matter the treatment or lack of interleukin-6. J Neurovirol (2011) 0.91
Experimental autoimmune encephalomyelitis as a testing paradigm for adjuvants and vaccines. Vaccine (2010) 0.91
Theiler's virus infection: Pathophysiology of demyelination and neurodegeneration. Pathophysiology (2011) 0.91
Resveratrol exacerbates both autoimmune and viral models of multiple sclerosis. Am J Pathol (2013) 0.90
Hyperserotoninemia and altered immunity in autism. J Autism Dev Disord (2006) 0.90
Neuronal uptake of anti-Hu antibody, but not anti-Ri antibody, leads to cell death in brain slice cultures. J Neuroinflammation (2014) 0.90
Modulation of experimental autoimmune encephalomyelitis by VLA-2 blockade. Brain Pathol (2007) 0.89
The importance of NAD in multiple sclerosis. Curr Pharm Des (2009) 0.89
Multiple sclerosis: autoimmunity and viruses. Curr Opin Rheumatol (2013) 0.89
Potential triggers of MS. Results Probl Cell Differ (2010) 0.87
Regulatory role of CD1d in neurotropic virus infection. J Virol (2008) 0.87
Converting relapsing remitting to secondary progressive experimental allergic encephalomyelitis (EAE) by ultraviolet B irradiation. J Neuroimmunol (2004) 0.87
IFN-gamma production and astrocyte recognition by autoreactive T cells induced by Theiler's virus infection: role of viral strains and capsid proteins. J Neuroimmunol (2005) 0.87
Human T cell expansion and experimental autoimmune encephalomyelitis inhibited by Lenaldekar, a small molecule discovered in a zebrafish screen. J Neuroimmunol (2012) 0.86
Are there enhanced MBP autoantibodies in autism? J Autism Dev Disord (2007) 0.86
Investigation of treatment failure in neonatal echovirus 7 infection. Pediatr Infect Dis J (2006) 0.86
Immunopathological patterns from EAE and Theiler's virus infection: Is multiple sclerosis a homogenous 1-stage or heterogenous 2-stage disease? Pathophysiology (2012) 0.85
Neurotropic viral infections leading to epilepsy: focus on Theiler's murine encephalomyelitis virus. Future Virol (2011) 0.85
Protective and detrimental roles for regulatory T cells in a viral model for multiple sclerosis. Brain Pathol (2014) 0.85
Sequential polymicrobial infections lead to CNS inflammatory disease: possible involvement of bystander activation in heterologous immunity. J Neuroimmunol (2007) 0.84
Therapeutic evaluation of ex vivo-generated versus natural regulatory T-cells in a mouse model of chronic gut inflammation. Inflamm Bowel Dis (2013) 0.83
Lack of correlation of central nervous system inflammation and neuropathology with the development of seizures following acute virus infection. J Virol (2011) 0.83
How relevant are GFAP autoantibodies in autism and Tourette Syndrome? J Autism Dev Disord (2007) 0.83
Modulation of immune system function by measles virus infection. II. Infection of B cells leads to the production of a soluble factor that arrests uninfected B cells in G0/G1. Viral Immunol (2003) 0.82
Role of pathogens in multiple sclerosis. Int Rev Immunol (2013) 0.82
Mutation in loop I of VP1 of Theiler's virus delays viral RNA release into cells and enhances antibody-mediated neutralization: a mechanism for the failure of persistence by the mutant virus. J Neurovirol (2002) 0.82
Role for antibodies in altering behavior and movement. Autism Res (2010) 0.81
Monoclonal MOG-reactive autoantibody from progressive EAE has the characteristics of a natural antibody. J Neuroimmunol (2006) 0.81
Targeting myelin proteolipid protein to the MHC class I pathway by ubiquitination modulates the course of experimental autoimmune encephalomyelitis. J Neuroimmunol (2008) 0.80
Downregulation of FoxC2 Increased Susceptibility to Experimental Colitis: Influence of Lymphatic Drainage Function? Inflamm Bowel Dis (2015) 0.80
Inflammation induces neuro-lymphatic protein expression in multiple sclerosis brain neurovasculature. J Neuroinflammation (2013) 0.80
Antiviral CD8⁺ T cells cause an experimental autoimmune encephalomyelitis-like disease in naive mice. J Neurovirol (2012) 0.79
Theiler's murine encephalomyelitis virus attachment to the gastrointestinal tract is associated with sialic acid binding. J Neurovirol (2008) 0.79
Polyreactive myelin oligodendrocyte glycoprotein antibodies: Implications for systemic autoimmunity in progressive experimental autoimmune encephalomyelitis. J Neuroimmunol (2007) 0.79
Neurons tame T cells. Nat Med (2006) 0.79
Infectious RNA isolated from the spinal cords of mice chronically infected with Theiler's murine encephalomyelitis virus. J Virol (2006) 0.79
Contrasting roles for Valpha14+ natural killer T cells in a viral model for multiple sclerosis. J Neurovirol (2008) 0.78
The activity within the CA3 excitatory network during Theiler's virus encephalitis is distinct from that observed during chronic epilepsy. J Neurovirol (2012) 0.78
Manganese superoxide dismutase induction during measles virus infection. J Med Virol (2003) 0.78
Discovery of biologically active oncologic and immunologic small molecule therapies using zebrafish: overview and example of modulation of T cell activation. Curr Protoc Pharmacol (2013) 0.78
Cross-reactive myelin antibody induces renal pathology. Autoimmunity (2008) 0.77
Venous endothelial injury in central nervous system diseases. BMC Med (2013) 0.77
Acthar gel treatment suppresses acute exacerbations in a murine model of relapsing-remitting multiple sclerosis. Autoimmunity (2014) 0.77
Distinct kinetics of viral replication, T cell infiltration, and fibrosis in three phases of myocarditis following Theiler's virus infection. Cell Immunol (2015) 0.76
In vitro antigen-specific induction of IL-22 in human subjects that resolved HCV infection. Future Virol (2012) 0.76
Heterogeneity versus homogeneity of multiple sclerosis. Expert Rev Clin Immunol (2011) 0.76
Letting antibodies get to your head. Nat Med (2003) 0.75
A Critical Role for Monocytes/Macrophages During Intestinal Inflammation-associated Lymphangiogenesis. Inflamm Bowel Dis (2016) 0.75
Possible role of interleukin-17 in a prime/challenge model of multiple sclerosis. J Neurovirol (2012) 0.75
A potential link between measles virus and autism: age-matched control groups are essential. Pediatr Neurol (2004) 0.75
Axonal pathology and demyelination in viral models of multiple sclerosis. Discov Med (2014) 0.75
Immunization with structural and non-structural proteins of Theiler's murine encephalomyelitis virus alters demyelinating disease. J Neurovirol (2012) 0.75
Role of B:T cell ratio in suppression of clinical signs: a model for silent MS. Exp Mol Pathol (2008) 0.75
Are there altered antibody responses to measles, mumps, or rubella viruses in autism? J Neurovirol (2007) 0.75
Altered cell growth and morphology in a BHK-21 cell mutant that lacks a receptor for Theiler's murine encephalomyelitis virus. Virology (2002) 0.75